Effect of apoptosis-inducing antitumor agents on endocardial endothelial cells

Cardiovascular Toxicology

Volumn 11, Issue 3, 2011, Pages 253-262

  Maney, Sathish Kumar ^a   Johnson, Ann Mary ^a   Kumar, A Sampath ^a   Nair, Vineet ^a   Santhosh Kumar, T R ^a   Kartha, C C ^a  

^a RAJIV GANDHI CENTRE FOR BIOTECHNOLOGY   (India)

Author keywords

Apoptosis; Chemotherapy; Cytotoxicity; Doxorubicin; Endocardial endothelial cells; Vascular endothelial cells

Indexed keywords

ANTINEOPLASTIC AGENT; CAMPTOTHECIN; DOXORUBICIN; THAPSIGARGIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CARDIOTOXICITY; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL POPULATION; CELLULAR DISTRIBUTION; CHROMATIN CONDENSATION; CONTROLLED STUDY; DNA CONTENT; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG SENSITIVITY; ENDOCARDIUM; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; NONHUMAN; PRIORITY JOURNAL; SWINE; UMBILICAL VEIN ENDOTHELIAL CELL;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CAMPTOTHECIN; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; ENDOCARDIUM; ENDOTHELIAL CELLS; G1 PHASE CELL CYCLE CHECKPOINTS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; S PHASE CELL CYCLE CHECKPOINTS; SWINE; THAPSIGARGIN;

SUS;

EID: 80054925772     PISSN: 15307905     EISSN: 15590259     Source Type: Journal    
DOI: 10.1007/s12012-011-9119-x     Document Type: Article

References (36)

1. Hong, R. A., Iimura, T., Sumida, K. N., & Eager, R. M. (2010). Cardio-oncology/onco-cardiology. Clinical Cardiology, 33, 733-737.
2. Hunley, T. E., Iwasaki, S., Homma, T., & Kon, V. (1995). Nitric oxide and endothelin in pathophysiological settings. Pediatric Nephrology, 9, 235-244.
3. Baudin, B., Beneteau-Burnat, B., & Giboudeau, J. (1996). Cytotoxicity of amiodarone in cultured human endothelial cells. Cardiovascular Drugs and Therapy, 10, 557-560. (Pubitemid 26375668)
4. Brutsaert, D. L., Fransen, P., Andries, L. J., De Keulenaer, G. W., & Sys, S. U. (1998). Cardiac endothelium and myocardial function. Cardiovascular Research, 38, 281-290. (Pubitemid 28294146)
5. Kuruvilla, L., & Kartha, C. C. (2003). Molecular mechanisms in endothelial regulation of cardiac function. Molecular and Cellular Biochemistry, 253, 113-123. (Pubitemid 37321717)
6. Tonini, T., Gabellini, C., Bagella, L., D'Andrilli, G., Masciullo, V., Romano, G., et al. (2004). pRb2/p130 decreases sensitivity to apoptosis induced by camptothecin and doxorubicin but not by taxol. Clinical Cancer Research, 10, 8085-8093. (Pubitemid 39587550)
7. Yamamoto, N., Watanabe, H., Kakizawa, H., Hirano, M., Kobayashi, A., & Ohno, R. (1995). A study on thapsigargin-induced calcium ion and cation influx pathways in vascular endothelial cells. Biochimica et Biophysica Acta, 1266, 157-162.
8. Baudin, B., Bruneel, A., Bosselut, N., & Vaubourdolle, M. (2007). A protocol for isolation and culture of human umbilical vein endothelial cells. Nature Protocols, 2, 481-485. (Pubitemid 47040010)
9. Andries, L. J., Kaluza, G., De Keulenaer, G. W., Mebazaa, A., Brutsaert, D. L., & Sys, S. U. (1996). Endocardial endothelial dysfunction and heart failure. Journal of Cardiac Failure, 2, S195-S202. (Pubitemid 126686409)
10. Kuruvilla, L., Santhosh Kumar, T. R., & Kartha, C. C. (2007). Immortalization and characterization of porcine ventricular endocardial endothelial cells. Endothelium, 14, 35-43. (Pubitemid 46978768)
11. Aird, W. C. (2007). Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms. Circulation Research, 100, 158-173. (Pubitemid 46208717)
12. Kwok, J. C., & Richardson, D. R. (2003). Anthracyclines induce accumulation of iron in ferritin in myocardial and neoplastic cells: Inhibition of the ferritin iron mobilization pathway. Molecular Pharmacology, 63, 849-861. (Pubitemid 36368992)
13. Lock, R. B., & Stribinskiene, L. (1996). Dual modes of death induced by etoposide in human epithelial tumor cells allow Bcl-2 to inhibit apoptosis without affecting clonogenic survival. Cancer Research, 56, 4006-4012. (Pubitemid 26284752)
14. Walker, P. R., Smith, C., Youdale, T., Leblanc, J., Whitfield, J. F., & Sikorska, M. (1991). Topoisomerase II-reactive chemo-therapeutic drugs induce apoptosis in thymocytes. Cancer Research, 51, 1078-1085.
15. Mailloux, A., Grenet, K., Bruneel, A., Beneteau-Burnat, B., Vaubourdolle, M., & Baudin, B. (2001). Anticancer drugs induce necrosis of human endothelial cells involving both oncosis and apoptosis. European Journal of Cell Biology, 80, 442-449. (Pubitemid 32605787)
16. Schimmel, K. J., Richel, D. J., van den Brink, R. B., & Guchelaar, H. J. (2004). Cardiotoxicity of cytotoxic drugs. Cancer Treatment Reviews, 30, 181-191. (Pubitemid 38418056)
17. Zunina, F., Gambetta, R., & Di Marco, A. (1975). The inhibition in vitro of DNA polymerase and RNA polymerases by dauno-mycin and adriamycin. Biochemical Pharmacology, 24, 309-311.
18. Iwamoto, Y., Hansen, I. L., Porter, T. H., & Folkers, K. (1974). Inhibition of coenzyme Q10-enzymes, succinoxidase and NADH-oxidase, by adriamycin and other quinones having antitumor activity. Biochemical and Biophysical Research Communications, 58, 633-638.
19. Corna, G., Santambrogio, P., Minotti, G., & Cairo, G. (2004). Doxorubicin paradoxically protects cardiomyocytes against iron-mediated toxicity: Role of reactive oxygen species and ferritin. Journal of Biological Chemistry, 279, 13738-13745. (Pubitemid 38468903)
20. L'Ecuyer, T., Sanjeev, S., Thomas, R., Novak, R., Das, L., Campbell, W., et al. (2006). DNA damage is an early event in doxorubicin-induced cardiac myocyte death. American Journal of Physiology. Heart and Circulatory Physiology, 291, H1273-H1280. (Pubitemid 44343672)
21. Pantazis, P. (1995). Preclinical studies of water-insoluble cam-ptothecin congeners: Cytotoxicity, development of resistance, and combination treatments. Clinical Cancer Research, 1, 1235-1244.
22. Ryan, A. J., Squires, S., Strutt, H. L., & Johnson, R. T. (1991). Camptothecin cytotoxicity in mammalian cells is associated with the induction of persistent double strand breaks in replicating DNA. Nucleic Acids Research, 19, 3295-3300. (Pubitemid 21912684)
23. Hsiang, Y. H., Liu, L. F., Wall, M. E., Wani, M. C., Nicholas, A. W., Manikumar, G., et al. (1989). DNA topoisomerase I-mediated DNA cleavage and cytotoxicity of camptothecin analogues. Cancer Research, 49, 4385-4389. (Pubitemid 19208330)
24. O'Leary, J. J., Shapiro, R. L., Ren, C. J., Chuang, N., Cohen, H. W., & Potmesil, M. (1999). Antiangiogenic effects of campto-thecin analogues 9-amino-20(S)-camptothecin, topotecan, and CPT-11 studied in the mouse cornea model. Clinical Cancer Research, 5, 181-187. (Pubitemid 29045192)
25. Feng, X. Q., You, Y., Xiao, J., & Zou, P. (2006). Thapsigargin-induced apoptosis of K562 cells and its mechanism. Zhongguo Shi Yan Xue Ye Xue Za Zhi, 14, 25-30.
26. Crow, M. T., Mani, K., Nam, Y. J., & Kitsis, R. N. (2004). The mitochondrial death pathway and cardiac myocyte apoptosis. Circulation Research, 95, 957-970. (Pubitemid 39532326)
27. Sarkar, S., Chawla-Sarkar, M., Young, D., Nishiyama, K., Rayborn, M. E., Hollyfield, J. G., et al. (2004). Myocardial cell death and regeneration during progression of cardiac hypertrophy to heart failure. Journal of Biological Chemistry, 279, 52630-52642. (Pubitemid 39656639)
28. Bernecker, O. Y., Huq, F., Heist, E. K., Podesser, B. K., & Hajjar, R. J. (2003). Apoptosis in heart failure and the senescent heart. Cardiovascular Toxicology, 3, 183-190. (Pubitemid 37296072)
29. Umansky, S. R., & Tomei, L. D. (2003). Apoptosis in the myocardium: Much is still expected. Expert Opinion on Therapeutic Targets, 7, 61-69 (Pubitemid 36204589)
30. deBlois, D., Orlov, S. N., & Hamet, P. (2001). Apoptosis in cardiovascular remodeling-effect of medication. Cardiovascular Drugs and Therapy, 15, 539-545. (Pubitemid 34163940)
31. Mercie, P., Garnier, O., Lascoste, L., Renard, M., Closse, C., Durrieu, F., et al. (2000). Homocysteine-thiolactone induces caspase-independent vascular endothelial cell death with apop-totic features. Apoptosis, 5, 403-411. (Pubitemid 32162622)
32. Kuruvilla, L., Nair, R. R., Umashankar, P. R., Lal, A. V., & Kartha, C. C. (2007). Endocardial endothelial cells stimulate proliferation and collagen synthesis of cardiac fibroblasts. Cell Biochemistry and Biophysics, 47, 65-72. (Pubitemid 46570699)
33. Fransen, P., Hendrickx, J., Brutsaert, D. L., & Sys, S. U. (2001). Distribution and role of Na(?)/K(?) ATPase in endocardial endothelium. Cardiovascular Research, 52, 487-499. (Pubitemid 33153112)
34. Flens, M. J., Zaman, G. J., van der Valk, P., Izquierdo, M. A., Schroeijers, A. B., Scheffer, G. L., et al. (1996). Tissue distribution of the multidrug resistance protein. American Journal of Pathology, 148, 1237-1247. (Pubitemid 26111082)
35. Cordon-Cardo, C., O'Brien, J. P., Boccia, J., Casals, D., Bertino, J. R., & Melamed, M. R. (1990). Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues. Journal of Histochemistry and Cytochemistry, 38, 1277-1287. (Pubitemid 20266126)
36. Sugawara, I., Kataoka, I., Morishita, Y., Hamada, H., Tsuruo, T., Itoyama, S., et al. (1988). Tissue distribution of P-glycoprotein encoded by a multidrug-resistant gene as revealed by a monoclonal antibody, MRK 16. Cancer Research, 48, 1926-1929.